Target intelligence / Profile preview

Catenin delta-1 (CTNND1)

Target
CTNND1
Molecular classification
Armadillo protein family, Cell adhesion molecule (non-canonical; not a receptor or transporter, but functionally related), Scaffold protein, Signal transduction regulator
01

Overview

Catenin delta-1 (CTNND1) encodes the protein p120-catenin, a member of the armadillo repeat-containing catenin family. p120-catenin interacts directly with classical cadherins (especially E-cadherin, CDH1) and is vital to the stability of cell-cell adhesion complexes in epithelial and mesenchymal tissues. It prevents endocytosis and premature degradation of cadherins, thereby maintaining adherens junctions. By functioning as a scaffolding protein, p120-catenin recruits and regulates RhoA GTPase, modulating actin cytoskeleton dynamics and cell motility. It also participates in signaling pathways that regulate gene expression and cell differentiation, including indirect modulation of NF-κB and Kaiso/Wnt transcription factors. CTNND1 is essential for normal craniofacial development, heart formation, and tissue differentiation, and genetic mutations cause human developmental syndromes such as blepharocheilodontic syndrome and cleft palate. The protein has multiple isoforms, with tissue-specific expression patterns detected in epithelial, mesenchymal, neural, and cardiac cells. If used in research, CTNND1 is best classified as a developmental and structural regulator rather than a classic receptor, enzyme, or transporter. It is implicated in disease primarily via genetic defects or dysregulation in cancer, rather than as a conventional pharmacologic target.

Other names
p120 cateninp120(ctn)p120(cas)p120catenin (cadherin-associated protein), delta 1cadherin-associated Src substrate (CAS)KIAA0384CTNNDP120CASP120CTNdelta catenincatenin delta-1catenin delta 1
02

Mechanism of action

Not applicable; no drugs directly target CTNND1. Indirectly altered via regulatory or pathway-based interventions (e.g., targeting the cadherin/catenin signaling axis in cancer research), but not by selective drugs.

03

Biological functions

Cell adhesion (mediated by cadherin–catenin complexes)Signal transductionRegulation of epithelial integrity and turnoverRegulation of epithelial-to-mesenchymal transition (EMT)Regulation of cell maturation and movementRegulator of transcriptional signaling (NF-κB, Kaiso/Wnt)Scaffold for RhoA and related proteinsGene expression regulation
04

Disease associations

Craniofacial congenital disorders (e.g., blepharocheilodontic syndrome, cleft palate)Neurodevelopmental disordersCongenital cardiac anomaliesCancer (role in oncogenesis, cell invasion, progression)Limb dysmorphology
05

Safety considerations

No direct safety concerns for drug targeting; pharmacological manipulation is not established. Genetic mutations are associated with developmental risk
06

Biomarkers

Loss/mutation of CTNND1 can serve as a genetic biomarker for blepharocheilodontic syndrome and possibly other craniofacial/cardiac congenital disorders

Beyond the preview

Go deeper on Catenin delta-1 (CTNND1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catenin delta-1 (CTNND1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call